(Q51795714)

12 April 2018

title

Copaxone interferes with the PrP Sc-GAG interaction. (English)

1 reference

12 April 2018

author name string

R Engelstein

series ordinal

1

1 reference

12 April 2018

H Ovadia

series ordinal

2

1 reference

12 April 2018

R Gabizon

series ordinal

3

1 reference

12 April 2018

publication date

1 August 2007

1 reference

12 April 2018

European Journal of Neurology

published in

1 reference

12 April 2018

volume

14

1 reference

12 April 2018

issue

8

1 reference

12 April 2018

page(s)

877-884

1 reference

12 April 2018

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

1 reference

Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

Evaluation of quinacrine treatment for prion diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

Antibodies inhibit prion propagation and clear cell cultures of prion infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

Elimination of prions by branched polyamines and implications for therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

Branched polyamines cure prion-infected neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

Antiprion immunotherapy: to suppress or to stimulate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

Complement facilitates early prion pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

Tumor necrosis factor alpha-deficient, but not interleukin-6-deficient, mice resist peripheral infection with scrapie

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

Gene expression profiling of scrapie-infected brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

Coincident scrapie infection and nephritis lead to urinary prion excretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

Binding of copolymer 1 and myelin basic protein leads to clustering of class II MHC molecules on antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

Immunomodulation by the copolymer glatiramer acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

Treatment of multiple sclerosis with Copaxone (COP): Elispot assay detects COP-induced interleukin-4 and interferon-gamma response in blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

Elispot assay detection of cytokine secretion in multiple sclerosis patients treated with interferon-b1a or glatiramer acetate compared with untreated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

Accelerated prion disease in the absence of interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

Glatiramer acetate (Copaxone): comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

Novel heparan mimetics potently inhibit the scrapie prion protein and its endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

Cell-surface prion protein interacts with glycosaminoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

Identification of the heparan sulfate binding sites in the cellular prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

A protease-resistant prion protein isoform is present in urine of animals and humans affected with prion diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

The most infectious prion protein particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

Chronic Lymphocytic Inflammation Specifies the Organ Tropism of Prions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

PrPSc in mammary glands of sheep affected by scrapie and mastitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01803.X

10.1111/J.1468-1331.2007.01803.X

21 January 2018

Identifiers

DOI

1 reference

12 April 2018

release_tyjo2ngpc5gc3nd4hyjot2vncu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tyjo2ngpc5gc3nd4hyjot2vncu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

12 April 2018